Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiang-Xu Wang

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Briefings in Bioinformatics|May 7, 2024
Predicting TCR sequences for unseen antigen epitopes using structural and sequence featuresHongchen Ji, Xiang-Xu Wang, Qiong Zhang, et al.
Medical Oncology (Northwood, London, England)|March 25, 2024
The efficacy and safety of PD-1 inhibitor combined with TACE in the first-line treatment of unresectable hepatocellular carcinomaQing-Qing Liu, Xiang-Xu Wang, Hongchen Ji, et al.
Frontiers in Surgery|September 12, 2022
Exploration of the Tumor Immune Landscape and Identification of Two Novel Immunotherapy-Related Genes for Epstein-Barr virus-associated Gastric Carcinoma <i>via</i> Integrated Bioinformatics AnalysisShi-Zhou Deng, Xiang-Xu Wang, Xing-Yu Zhao, et al.
Molecular Therapy. Oncology|November 5, 2024
Stratifying hepatocellular carcinoma based on immunophenotypes for immunotherapy response and prognosisYunpeng Liu, Hongchen Ji, Li-Hong Wu, et al.
Frontiers in Surgery|April 17, 2023
Construction and validation of a prognosis signature based on the immune microenvironment in gastric cancerLi-Hong Wu, Xiang-Xu Wang, Yan Wang, et al.
Frontiers in Genetics|July 31, 2025
Characterization of lactylation modification subtypes and the promoting role of CCL20 in hepatocellular carcinoma progressionLi-Hong Wu, Liu Yang, Xiang-Xu Wang, et al.
Molecular Therapy. Nucleic Acids|December 13, 2021
Construction of an HCC recurrence model basedon the investigation of immune-relatedlncRNAs and related mechanismsXiang-Xu Wang, Li-Hong Wu, Liping Ai, et al.
Discover Oncology|August 25, 2022
Identification of stromal microenvironment characteristics and key molecular mining in pancreatic cancerHongchen Ji, Qiong Zhang, Xiang-Xu Wang, et al.
Clinical Genitourinary Cancer|August 7, 2024
The Clinicopathological Characteristics and Prognosis of 55 Patients With TFE3-Rearranged Renal Cell CarcinomasYin-Miao Bai, Li Yang, Yue Yang, et al.
Frontiers in Immunology|May 9, 2024
Identifying specific TLS-associated genes as potential biomarkers for predicting prognosis and evaluating the efficacy of immunotherapy in soft tissue sarcomaXiang-Xu Wang, Yun-Peng Liu, Yajie Lu, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Briefings in Bioinformatics|May 7, 2024
Predicting TCR sequences for unseen antigen epitopes using structural and sequence featuresHongchen Ji, Xiang-Xu Wang, Qiong Zhang, et al.
Medical Oncology (Northwood, London, England)|March 25, 2024
The efficacy and safety of PD-1 inhibitor combined with TACE in the first-line treatment of unresectable hepatocellular carcinomaQing-Qing Liu, Xiang-Xu Wang, Hongchen Ji, et al.
Frontiers in Surgery|September 12, 2022
Exploration of the Tumor Immune Landscape and Identification of Two Novel Immunotherapy-Related Genes for Epstein-Barr virus-associated Gastric Carcinoma <i>via</i> Integrated Bioinformatics AnalysisShi-Zhou Deng, Xiang-Xu Wang, Xing-Yu Zhao, et al.
Molecular Therapy. Oncology|November 5, 2024
Stratifying hepatocellular carcinoma based on immunophenotypes for immunotherapy response and prognosisYunpeng Liu, Hongchen Ji, Li-Hong Wu, et al.
Frontiers in Surgery|April 17, 2023
Construction and validation of a prognosis signature based on the immune microenvironment in gastric cancerLi-Hong Wu, Xiang-Xu Wang, Yan Wang, et al.
Frontiers in Genetics|July 31, 2025
Characterization of lactylation modification subtypes and the promoting role of CCL20 in hepatocellular carcinoma progressionLi-Hong Wu, Liu Yang, Xiang-Xu Wang, et al.
Molecular Therapy. Nucleic Acids|December 13, 2021
Construction of an HCC recurrence model basedon the investigation of immune-relatedlncRNAs and related mechanismsXiang-Xu Wang, Li-Hong Wu, Liping Ai, et al.
Discover Oncology|August 25, 2022
Identification of stromal microenvironment characteristics and key molecular mining in pancreatic cancerHongchen Ji, Qiong Zhang, Xiang-Xu Wang, et al.
Clinical Genitourinary Cancer|August 7, 2024
The Clinicopathological Characteristics and Prognosis of 55 Patients With TFE3-Rearranged Renal Cell CarcinomasYin-Miao Bai, Li Yang, Yue Yang, et al.
Frontiers in Immunology|May 9, 2024
Identifying specific TLS-associated genes as potential biomarkers for predicting prognosis and evaluating the efficacy of immunotherapy in soft tissue sarcomaXiang-Xu Wang, Yun-Peng Liu, Yajie Lu, et al.
Pageof 2